BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31246627)

  • 1. Genetics of vascular malformation and therapeutic implications.
    Zúñiga-Castillo M; Teng CL; Teng JMC
    Curr Opin Pediatr; 2019 Aug; 31(4):498-508. PubMed ID: 31246627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes associated with vascular malformations.
    Fereydooni A; Dardik A; Nassiri N
    J Vasc Surg; 2019 Jul; 70(1):314-326.e1. PubMed ID: 30922748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.
    Pang C; Lim CS; Brookes J; Tsui J; Hamilton G
    Vasc Med; 2020 Aug; 25(4):364-377. PubMed ID: 32568624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.
    Ye C; Pan L; Huang Y; Ye R; Han A; Li S; Li X; Wang S
    J Vasc Surg; 2011 Dec; 54(6):1760-8. PubMed ID: 21962923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular anomalies: Classification and management.
    Narsinh KH; Gautam A; Baker A; Cooke DL; Dowd CF
    Handb Clin Neurol; 2021; 176():345-360. PubMed ID: 33272404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular anomalies of the head and neck: a review of genetics.
    Yadav P; De Castro DK; Waner M; Meyer L; Fay A
    Semin Ophthalmol; 2013; 28(5-6):257-66. PubMed ID: 24010650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis for vascular anomalies.
    Kirkorian AY; Grossberg AL; Püttgen KB
    Semin Cutan Med Surg; 2016 Sep; 35(3):128-36. PubMed ID: 27607321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA mutations in vascular malformations.
    Castillo SD; Baselga E; Graupera M
    Curr Opin Hematol; 2019 May; 26(3):170-178. PubMed ID: 30855339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.
    Cetinkaya A; Xiong JR; Vargel İ; Kösemehmetoğlu K; Canter Hİ; Gerdan ÖF; Longo N; Alzahrani A; Camps MP; Taskiran EZ; Laupheimer S; Botto LD; Paramalingam E; Gormez Z; Uz E; Yuksel B; Ruacan Ş; Sağıroğlu MŞ; Takahashi T; Reversade B; Akarsu NA
    Am J Hum Genet; 2016 Aug; 99(2):299-317. PubMed ID: 27476657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How we approach genetics in the diagnosis and management of vascular anomalies.
    Setty BA; Wusik K; Hammill AM
    Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29320. PubMed ID: 36070212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
    Du Z; Zheng J; Zhang Z; Wang Y
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling pathway is a potential therapeutic target for extracranial vascular malformations.
    Davis RB; Pahl K; Datto NC; Smith SV; Shawber C; Caron KM; Blatt J
    Sci Rep; 2018 Dec; 8(1):17987. PubMed ID: 30573741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular anomalies: molecular bases, genetic testing and therapeutic approaches.
    Paolacci S; Zulian A; Bruson A; Manara E; Michelini S; Mattassi RE; Lee BB; Amato B; Bertelli M
    Int Angiol; 2019 Apr; 38(2):157-170. PubMed ID: 30938497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Basis and Therapies for Vascular Anomalies.
    Queisser A; Seront E; Boon LM; Vikkula M
    Circ Res; 2021 Jun; 129(1):155-173. PubMed ID: 34166070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of vascular anomalies.
    Frigerio A; Stevenson DA; Grimmer JF
    Curr Opin Otolaryngol Head Neck Surg; 2012 Dec; 20(6):527-32. PubMed ID: 22913934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Molecular Therapies for Venous Malformations.
    Kangas J; Nätynki M; Eklund L
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():6-19. PubMed ID: 29668117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.
    Greene AK; Goss JA
    Plast Reconstr Surg; 2018 May; 141(5):709e-717e. PubMed ID: 29697621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin and treatment of venous malformations.
    Seront E; Van Damme A; Boon LM; Vikkula M
    Curr Opin Hematol; 2019 May; 26(3):185-192. PubMed ID: 30855337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathobiology of vascular malformations: insights from human and model organism genetics.
    Wetzel-Strong SE; Detter MR; Marchuk DA
    J Pathol; 2017 Jan; 241(2):281-293. PubMed ID: 27859310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms.
    Butnariu LI; Gorduza EV; Florea L; Țarcă E; Moisă ȘM; Trandafir LM; Stoleriu S; Bădescu MC; Luca AC; Popa S; Radu I; Cojocaru E
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.